Dermatologie Quist
- Address
- Haifa-Allee 20, 55128 Mainz, Germany
Dermatologie Quist - Advanced Dermatological Research Center
Dermatologie Quist is a specialized dermatological research center dedicated to advancing treatment options for a wide spectrum of skin conditions. The center demonstrates particular expertise in evaluating novel therapeutic approaches for both inflammatory and infectious dermatological disorders, participating in pivotal phase 3 clinical trials that shape the future of dermatological care.
- Chronic inflammatory skin conditions including psoriasis, hidradenitis suppurativa, and chronic spontaneous urticaria
- Fungal and yeast skin infections, particularly candidiasis management with combination therapies
- Precancerous skin lesions including actinic keratosis treatment on the scalp and face
- Novel oral and topical therapeutic formulations for dermatological conditions
The center's research portfolio encompasses evaluation of innovative biologic therapies such as izokibep and barzolvolimab, as well as botanical-derived treatments like sinecatechins from green tea extracts. Their comprehensive approach includes both systemic oral therapies and topical formulations, with particular focus on dose-finding studies and comparative effectiveness research. This diverse experience positions Dermatologie Quist at the forefront of translating cutting-edge dermatological research into clinical practice.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 30 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Dermatologie Quist
lock Showing 1 of 25 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicenter, randomized, double-blind, placebo-controlled, Phase II platform study to assess the efficacy and safety of investigational compound(s) in patients with moderate to severe atopic dermatitis | Novartis Pharma AG | Phase II | Recruiting | Oct 2025 | — |
IMP list
lock Showing 1 of 30 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amlitelimab | 4 | Unknown | 2022-11-10 | 2024-10-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.